Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT06607601

Completed

CARE Initiative: Real-world Emulation of the PALOMA-2 Trial

Metastatic Breast Cancer
NCT04728035

Completed

Study of Irinotecan Liposome Injection in Patients With Advanced Breast Cance

Advanced Breast Cancer
NCT06395896

Completed

The Effect of Breast Cancer Prevention Journey Program

Breast Cancer Female
NCT03493854

Completed

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer (FeDeriCa)

Early Breast Cancer
NCT04862143

Terminated

Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant (TELEPIK)

Advanced Breast Cancer
NCT01377324

Completed

Molecular Imaging of Fulvestrant Effects on Availability of ER Binding Sites

Metastatic Breast Cancer
NCT03087409

Completed

High-dose Chemotherapy With Hematopoietic Stem-cell Rescue for High-risk Breast Cancer: Long-term Follow-up

Breast Cancer Female
NCT04087057

Completed

Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer

Invasive Breast Carcinoma
NCT05043506

Completed

European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies (EUCHARIS)

Metastatic Breast Cancer
NCT06321666

Active, not recruiting

Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone (RESPECT-MI)

Metastatic Breast Cancer
NCT06176339

Active, not recruiting

Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients"

Breast Cancer Female
NCT02536742

Completed

Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer (PYTHIA)

Metastatic Breast Cancer
NCT06025799

Completed

Effect of Mindfulness-based Stress Reduction Intervention on Psychological Distress and Hope Among Female Patients Undergoing Radiotherapy for Breast Cancer

Breast Cancer Female
NCT00634634

Completed

Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer

Metastatic Breast Cancer
NCT04165993

Active, not recruiting

Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer

Metastatic Breast Cancer
NCT02649686

Completed

Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab

Metastatic Breast Cancer
NCT05677737

Completed

Women on Breast Cancer Health Belıefs and Screenıng Behavıors

Breast Cancer Female
NCT05931042

Completed

Neoadjuvant Therapy With Trastuzumab and Chemotherapy and the Resultant Pathologic Complete Response Observed in HER2 Positive Breast Cancer;a Systematic Review

HER2+ Breast Cancer
NCT00921115

Completed

Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

Invasive Breast Cancer
NCT00597597

Terminated

Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer

Metastatic Breast Cancer
NCT04293276

Active, not recruiting

Study to Evaluate the Efficacy and Safety of SHR6390 Combined With Pyrotinib in HER2+ Advanced Breast Cancer (DAP-Her-01)

Metastatic Breast Cancer
NCT05840068

Completed

IGF Level in Breast Cancer Patients Treated With Metformin

Breast Cancer Female
NCT04097756

Completed

A Phase I Study of LX-039 Tablets

Advanced Breast Cancer
NCT05758948

Active, not recruiting

Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer

Metastatic Breast Cancer
NCT01725633

Completed

Aerobic Training in Metastatic Breast Cancer (Breast Mets)

Metastatic Breast Cancer
NCT03025880

Completed

Trial to Evaluate Efficacy and Safety of Pembrolizumab and Gemcitabine in HER2-negative ABC (PANGEA)

Advanced Breast Cancer
NCT01306942

Completed

Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients

Metastatic Breast Cancer
NCT04252768

Withdrawn

A Study in Hormone Receptor-positive Metastatic Breast Carcinoma Patients to Test a New Schedule of Efti (IMP321, Eftilagimod Alpha) as Adjunctive to a Weekly Treatment Regimen of Paclitaxel (AIPAC-002)

Metastatic Breast Cancer
NCT02990845

Terminated

Pembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast Cancer (PEER)

Premenopausal Breast Cancer
NCT05734950

Enrolling by invitation

Biological Characteristics of Older Women (> 70 Years) With ER Positive, HER2 Negative Early Breast Cancer (BOLD-70)

Breast Cancer Female
NCT05730647

Active, not recruiting

Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients (GIM 23- POSTER)

Early Breast Cancer
NCT02479230

Completed

Type I-Polarized Autologous Dendritic Cell Vaccine With Tumor Blood Vessel Antigen-Derived Peptides in Metastatic Breast Cancer Patients

Breast Cancer | Metastatic Breast Cancer
NCT05591456

Completed

Accelerated Hypofractionated 1 Week Radiotherapy in Breast Cancer Patients

Breast Cancer Radiotherapy
NCT02650817

Completed

Phase IB Study to Evaluate RAD1901 on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast Cancer

Metastatic Breast Cancer
NCT01989780

Completed

Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer (BOOSTER)

Metastatic Breast Cancer
NCT02563925

Completed

Brain Irradiation and Tremelimumab in Metastatic Breast Cancer

Metastatic Breast Cancer
NCT02000596

Terminated

1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.

Metastatic Breast Cancer
NCT04992156

Completed

Prediction of 18F-FES-PET/CT Parameters on Palbociclib Combined With ET

Metastatic Breast Cancer
NCT01033032

Completed

Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer

Metastatic Breast Cancer
NCT04398914

Active, not recruiting

Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Breast Cancer Invasive
NCT01036113

Terminated

A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer (PEG-SN38)

Metastatic Breast Cancer
NCT01019616

Active, not recruiting

Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy

Primary Breast Cancer
NCT03057743

Terminated

Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer

METASTATIC BREAST CANCER
NCT01934335

Terminated

Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer

Invasive Breast Cancer
NCT01802970

Completed

Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients

Metastatic Breast Cancer
NCT04061863

Active, not recruiting

Nivolumab and Eribulin in HER2 Negative Metastatic Breast Cancer (KORNELIA)

Metastatic Breast Cancer
NCT04879888

Completed

Personalized Vaccine for Cancer Immunotherapy

Breast Cancer Female
NCT03624972

Completed

Addressing Sexual Concerns in Breast Cancer: Patient Intervention Study

Breast Cancer Female
NCT02362230

Terminated

Evaluation of Icotinib in Metastatic Triple-negative Breast Cancer After Second-line Therapy

Metastatic Breast Cancer
NCT03564899

Completed

The Breast Cancer & Physical Activity Level (BC-PAL) Pilot Study (BC-PAL)

Breast Cancer Survivorship

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations